State Street’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.2M Sell
561,730
-514,263
-48% -$7.94M ﹤0.01% 2850
2025
Q4
$21.9M Sell
1,075,993
-226,985
-17% -$3.98M ﹤0.01% 2218
2025
Q3
$20.6M Sell
1,302,978
-81,276
-6% -$1.2M ﹤0.01% 2227
2025
Q2
$18.5M Buy
1,384,254
+81,715
+6% +$1.1M ﹤0.01% 2231
2025
Q1
$13.3M Buy
1,302,539
+99,156
+8% +$1.15M ﹤0.01% 2355
2024
Q4
$19M Buy
1,203,383
+89,793
+8% +$4.67M ﹤0.01% 2254
2024
Q3
$64.7M Sell
1,113,590
-107,786
-9% -$5.32M ﹤0.01% 1568
2024
Q2
$55.8M Sell
1,221,376
-341,519
-22% -$18.4M ﹤0.01% 1617
2024
Q1
$103M Buy
1,562,895
+508,528
+48% +$30.2M ﹤0.01% 1282
2023
Q4
$41.9M Buy
1,054,367
+152,367
+17% +$4.78M ﹤0.01% 1798
2023
Q3
$28.8M Sell
902,000
-113,903
-11% -$4.25M ﹤0.01% 1948
2023
Q2
$40.8M Buy
1,015,903
+71,744
+8% +$3.15M ﹤0.01% 1792
2023
Q1
$40.3M Sell
944,159
-23,979
-2% -$1.21M ﹤0.01% 1794
2022
Q4
$46.5M Buy
968,138
+34,626
+4% +$1.62M ﹤0.01% 1689
2022
Q3
$35.1M Sell
933,512
-57,240
-6% -$1.98M ﹤0.01% 1850
2022
Q2
$27.4M Buy
990,752
+307,105
+45% +$13.5M ﹤0.01% 2024
2022
Q1
$37.2M Buy
683,647
+28,655
+4% +$1.47M ﹤0.01% 1940
2021
Q4
$38.3M Sell
654,992
-22,276
-3% -$1.11M ﹤0.01% 1999
2021
Q3
$26.8M Sell
677,268
-1,710
-0.3% -$60.9K ﹤0.01% 2268
2021
Q2
$28.8M Sell
678,978
-44,845
-6% -$2.43M ﹤0.01% 2266
2021
Q1
$44.6M Buy
723,823
+297,732
+70% +$18.9M ﹤0.01% 1819
2020
Q4
$30.1M Buy
426,091
+326,865
+329% +$20.6M ﹤0.01% 1979
2020
Q3
$3.83M Buy
99,226
+14,215
+17% +$564K ﹤0.01% 2915
2020
Q2
$3.19M Buy
+85,011
New +$2.62M ﹤0.01% 2990

Other funds holding KROS